Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population

Author： Tian Jun   Qin Xueying   Fang Kai   Chen Qing   Hou Jing   Li Juan   Yu Wenzhen   Chen Dafang   Hu Yonghua   Li Xiaoxin  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.7, 2012-05, pp. : 779-787

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey   Mrejen Sarah   Gallego-Pinazo Roberto  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Potential Therapies

By Chappelow Aimee V.   Kaiser Peter K.  

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1029-1036

Adis International

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew   Kaiser Peter K  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

By Moshfeghi Andrew A   Puliafito Carmen A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 671-682

Informa Healthcare

Access to resources Recommend Favorite

VEGF inhibitors for the treatment of neovascular age-related macular degeneration

By Barakat Mark Rami   Kaiser PK  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 637-646

Informa Healthcare

Access to resources Recommend Favorite